Trial Profile
Phase2 Study of NT-702 in Patients With Adult Bronchial Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 May 2016
Price :
$35
*
At a glance
- Drugs Parogrelil (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Nissan Chemical Industries; Taisho Pharmaceutical
- 08 Dec 2015 New trial record